Nu Skin Enterprises (NYSE:NUS) Releases Q4 2024 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.190-0.290 for the period, compared to the consensus estimate of 0.200. The company issued revenue guidance of $410.0 million-$445.0 million, compared to the consensus revenue estimate of $441.0 million. Nu Skin Enterprises also updated its FY 2024 guidance to 0.650-0.750 EPS.

Analysts Set New Price Targets

NUS has been the topic of several analyst reports. DA Davidson reduced their price objective on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th. StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, October 23rd. Finally, Citigroup decreased their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a report on Tuesday, October 22nd.

Nu Skin Enterprises Stock Performance

NYSE:NUS traded down $0.03 during trading hours on Thursday, reaching $6.45. The company had a trading volume of 1,132,522 shares, compared to its average volume of 844,782. The firm’s 50 day moving average price is $6.90 and its 200-day moving average price is $9.93. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The firm has a market cap of $320.57 million, a price-to-earnings ratio of -2.16 and a beta of 1.14. Nu Skin Enterprises has a 52 week low of $5.95 and a 52 week high of $20.75.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. The business had revenue of $439.10 million for the quarter, compared to analysts’ expectations of $431.87 million. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business’s revenue for the quarter was down 12.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.54 EPS. On average, analysts forecast that Nu Skin Enterprises will post 0.78 EPS for the current year.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.